FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

Visiting Professor from Harvard University is guest at FOR 2240 and CMMC in Cologne

Augenklinik, Veranstaltung „Visiting Scientist Ksander“, v.l.: Prof. Claus Cursiefen, Dr. Maria Notara, Prof. Bruce Ksander (Schepens ERI & Harvard, Massachusetts, USA), Dr. Jacobus Bosch (Uniklinik Erlangen-Nürnberg), Prof. Ludwig Heindl

On 21st of June 2019 Prof. Bruce Ksander visited the DFG Research Unit FOR 2240 and the Center for Molecular Medicine at University Hospital Cologne. Prof. Ksander is Associate Professor at the Department of Ophthalmology at Harvard Medical School and Co-director of the MEEI Oncology Center of Excellence. His team recently demonstrated the link of ABCB5 to limbal epithelial stem cell function as well as corneal epithelium regeneration, morphogenesis and development (Ksander et al., Nature, 2014). Dr. Ksander’s group is currently working on several projects including the development of novel regenerative therapeutic strategies for the eye as well as a gene therapy approach in glaucoma. During his visit Prof. Ksander gave a lecture at CMMC with the topic: Reversal of ageing-and injury-induced vision loss by epigenetic reprogramming. He met with the principal investigators of the FOR2240 projects P1, N2 and P4 with which he has active collaborations involving respectively the role of ABCB5 in corneal neovascularization as well as pterygium and in ocular melanoma.

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck